Sign up to save your podcasts
Or
Share Wildcard: The Next Nano-X, But With Less Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Wildcard: The Next Nano-X, But With Less Risk
HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC.
Stocks: HealthCor Catalio Acquisition Corp (HCAQ)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ [email protected]
View all episodes
By The Motley FoolHyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC.
Stocks: HealthCor Catalio Acquisition Corp (HCAQ)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ [email protected]